This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: The Innovations of Raul Enrique Isturiz
Introduction
Raul Enrique Isturiz is a notable inventor based in Norristown, PA (US). He has made significant contributions to the field of immunology, particularly through his innovative work on immunogenic compositions. With a total of 2 patents, his inventions focus on enhancing vaccination strategies against pneumococcal infections.
Latest Patents
Isturiz's latest patents include groundbreaking immunogenic compositions that comprise conjugated capsular saccharide antigens. These glycoconjugates are designed to provide effective vaccination for human subjects, especially infants and the elderly. His inventions aim to address serotypes not found in existing vaccines such as PREVNAR®, SYNFLORIX®, and PREVNAR 13®. The applications of these immunogenic compositions are crucial for improving public health and preventing pneumococcal infections.
Career Highlights
Raul Enrique Isturiz is currently associated with Pfizer Corporation, a leading pharmaceutical company known for its commitment to innovation in healthcare. His work at Pfizer has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Ralf Rene Reinert and Luis Pascual Jodar Martin-Montalvo. Their collaborative efforts contribute to the advancement of immunological research and the development of effective vaccines.
Conclusion
Raul Enrique Isturiz's contributions to immunology through his patents and work at Pfizer Corporation highlight the importance of innovation in healthcare. His efforts in developing new immunogenic compositions are paving the way for improved vaccination strategies against pneumococcal infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
